Startups

Workwize: $13 Million (Series A) Raised To Transform IT Asset Management

By Amit Chowdhry ● Jan 17, 2025

Workwize, a platform for global IT hardware asset management, announced that it closed $13 million in Series A funding led by Klass Capital, with continued support from early-stage investors Peak and Graduate Entrepreneur Fund. This funding will fast-track Workwize's integration of AI-based automation, making it the first platform to fully automate the IT equipment lifecycle—from procurement and deployment to retrieval and disposal.

Teal Health: $10 Million (Seed) Closed To Launch Wand For At-Home Cervical Cancer Screening

By Amit Chowdhry ● Jan 17, 2025

Teal Health, a women's health company with a goal of eliminating cervical cancer in the US, announced the closing of an additional $10 million in seed funding to support the upcoming launch of the Teal Wand, which is currently under FDA review and on track to be the US market's first FDA-approved at-home self-collect cervical cancer screening device. And this new funding round brings Teal Health's funding to $23 million to date as the company accelerates its product development and readies go-to-market plans.

Micron Biomedical: Series A Funding Extended To Over $33 Million

By Amit Chowdhry ● Jan 17, 2025

Micron Biomedical, a life science company that is developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable microarrays, today announced it secured over $16 million in a Series A3 financing round, bringing the Series A equity raise total to over $33 million. J2 Ventures and the Global Health Investment Corporation (GHIC) led the round which will expand commercial manufacturing of Micron’s technology.

Ashvattha: $50 Million (Series B Extension) Raised For Developing Nanomedicine Therapeutics

By Amit Chowdhry ● Jan 17, 2025

Ashvattha Therapeutics - a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in regions of inflammation - announced additional financing as an extension of its Series B of up to $50 million led by Tribe Capital with existing investors led by Natural Capital. This funding will enable Ashvattha to complete the ongoing Phase 2 ophthalmology trial and Phase 1/2 neuroinflammation trial.

Holly: $2.2 Million Raised To Modernize Government Hiring

By Amit Chowdhry ● Jan 16, 2025

Holly, an AI-based platform modernizing government hiring, announced the closing of its $2.2 million oversubscribed pre-seed round, led by J2 Ventures with participation from Roble Ventures, Gaingels, and prominent angel investors. This funding will support Holly's platform as it works to solve the million-job government workforce vacancy crisis.

Ouro Medicines: $120 Million Raised For Developing Immune Reset Therapeutics

By Amit Chowdhry ● Jan 16, 2025

Ouro Medicines, a biotechnology company creating immune reset therapeutics for people living with chronic immune-mediated diseases, announced its launch with $120 million in funding. And the company was launched by Monograph Capital in partnership with GSK plc. And the Series A funding round was co-led by TPG Life Sciences Innovations, NEA, and Norwest Venture Partners, with participation from Monograph Capital, GSK, UPMC Enterprises, Boyu/Zoo Capital, LongRiver Investments, and other unnamed investors.

Overhaul: $55 Million Raised For Advancing Supply Chain Risk Management Platform

By Amit Chowdhry ● Jan 16, 2025

Overhaul, an industry leader in active supply chain risk management and intelligence, announced the completion of $55 million in equity funding led by Springcoast Partners, with follow-on participation from existing investors Edison Partners and Americo. The growth investment from Springcoast will fuel Overhaul's continued advancements in AI and support its strategic acquisition roadmap.

Phase Four: In-Space Propulsion Design Company Raises Series C Funding

By Amit Chowdhry ● Jan 16, 2025

Phase Four, a leader in advanced in-space propulsion design and manufacturing, announced the first closing of its Series C funding round. The company has secured nearly 60% of the target raise with strong participation from new and existing investors. The funding round was led by Artemis Group Capital, the Oklahoma-based investment firm helmed by former NASA Administrator Jim Bridenstine, underscoring the growing confidence in Phase Four's innovative propulsion solutions.

Timberlyne Therapeutics: $180 Million (Series A) Raised For Advancing CM313

By Amit Chowdhry ● Jan 16, 2025

Timberlyne Therapeutics - a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders - announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-class monoclonal antibody targeting CD38, for diseases of high unmet medical needs. The funding was led by investors Abingworth, Bain Capital Life Sciences, and Venrock Healthcare Capital Partners, with participation from Boyu Capital, Lilly Asia Ventures, Braidwell LP, and 3H Health Investment.

ControlMonkey: $7 Million (Seed) Raised By AI-Based Cloud Infrastructure Platform Company

By Amit Chowdhry ● Jan 16, 2025

ControlMonkey, an end-to-end cloud automation platform offering "Total Cloud Control with Terraform," announced its global launch and the close of a $7 million seed round, co-led by lool ventures and Joule Ventures. This funding round will accelerate the development of ControlMonkey's cloud governance tools and expand its global operations, including significant investments in engineering, customer success, and go-to-market initiatives.

Rockfish: $4 Million (Seed) Raised For Advancing Synthetic Generation Data Platform

By Amit Chowdhry ● Jan 16, 2025

Rockfish Data, a leader in synthetic data generation for operational workflows, announced the closing of a $4 million seed fundraising round. This funding round was led by Emergent Ventures with participation from Foster Ventures, TEN13, Dallas VC, NewBuild Venture Capital, and others. This brings the total amount raised close to $6 million.

Lyteflo: $3 Million (Seed) Closed To Advance EV Merchandising Solution Platform

By Amit Chowdhry ● Jan 16, 2025

Electric vehicle (EV) merchandising solution Lyteflo announced $3 million in seed funding. Launched by Ryan Osten (CEO) and Dominick Rivard (CTO), Lyteflo seamlessly integrates into dealership websites to help auto dealers move their EV inventory faster and appraise EV batteries with precision: a one-stop shop to help dealerships win the electric future. And Diagram led the oversubscribed round, with participation from Whitecap Venture Partners and Amplify Capital.

Netradyne: $90 Million (Series D) Raised By AI-Based Fleet Safety Solutions Company

By Amit Chowdhry ● Jan 16, 2025

Netradyne, a SaaS provider of artificial intelligence (AI) and edge computing, announced closing a $90 million Series D round led by Point72 Private Investments with participation from Qualcomm Ventures and Pavilion Capital. The funding will accelerate the company’s growth trajectory through strategic investment in R&D, enhanced go-to-market investments, and aggressive global expansion, solidifying Netradyne as a worldwide industry leader in commercial fleet technology.

Coram AI: $13.8 Million (Series A) Raised For Enhancing Video Security Platform

By Amit Chowdhry ● Jan 16, 2025

Coram AI, an innovator in LLM-powered video security, announced it raised $13.8 million in Series A funding in a round led by Battery Ventures. And existing investors 8VC and Mosaic Ventures also participated in the round.

Truveta: EHR Data Company Raises $320 Million At Over $1 Billion Valuation

By Amit Chowdhry ● Jan 16, 2025

Leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announced the Truveta Genome Project, which is an innovative collaboration to generate genetic data on tens of millions of consented and de-identified volunteers, creating the largest and most diverse database of genotypic and phenotypic information ever assembled. For this initiative, 17 health systems, including Regeneron and Illumina, have invested $320 million in Truveta preferred equity at a valuation exceeding $1 billion. As part of this deal, Regeneron has made a strategic investment of $119.5 million upfront (as part of Truveta’s Series C financing round), enabling the advancement of discovery and development of new therapies and the development of next-generation solutions for healthcare delivery and population health management. And Illumina, a global leader in DNA sequencing and array-based technologies, will invest $20 million. This builds on the previously announced strategic investment Microsoft made into Truveta.

Reown: Onchain UX Platform Company Raises $13 Million (Series B)

By Amit Chowdhry ● Jan 16, 2025

Reown (previously known as WalletConnect) announced it has closed a $13 million Series B funding round. USV and 1kx led the funding round and it also included Global Digital Asset Holdings (a joint venture investment vehicle established by SC Ventures and SBI Holdings), Shopify Ventures, Kraken Ventures, Crypto.com Capital, Figment, Kiln, Everstake, BitGo Ventures, and Fenbushi. So far, Reown has raised a total of $38 million from some of the most prominent investors in Web 2 and web3.

Light Horse: $62 Million (Series A) Raised For Developing Small Molecule Therapeutics

By Amit Chowdhry ● Jan 16, 2025

Light Horse Therapeutics - a developer of first-in-class small molecule therapeutics - announced a $62 million Series A funding round. This funding was led by founding investor Versant Ventures and included Mubadala Capital as well as three strategic investors: Bristol-Myers Squibb Co, Taiho Ventures, and AbbVie. And Light Horse is the latest company started by Versant’s Inception Discovery Engine, and its scientific co-founders are Brian Liau, PhD, Ben Cravatt, PhD, and Nathanael Gray, PhD.

Matic: $30 Million Raised For Advancing Embedded Insurance Technology Expansion

By Amit Chowdhry ● Jan 16, 2025

Leading insurance technology platform Matic Insurance Services announced it has secured $30 million from Vistara Growth, a provider of flexible growth capital to software and technology enabled services companies. And Matic offers an embedded insurance platform to mortgage servicers, originators, banks and other financial institutions to seamlessly offer home, auto, and other personal lines products to their customers.

Neumirna Therapeutics: €20 Million (Series A) Raised To Develop RNA Therapies For Neurological Disorders

By Amit Chowdhry ● Jan 16, 2025

Neumirna Therapeutics - an RNA-focused biotech company developing next-generation therapeutics for neurological disorders - announced the first closing of its Series A funding round at €20 million. New investors Angelini Ventures and Invivo Partners co-led the funding, with significant participation from Neumirna’s seed investor, Innovestor’s Life Science Fund, and other investors.

Coave Therapeutics: €32 Million (Series A) Raised For Advancing Genetic Medicines

By Amit Chowdhry ● Jan 16, 2025

Coave Therapeutics - a company advancing the future of genetic medicines - announced the raising of €32 million ($33 million) in Series A funding. The funding was co-led by Novo Holdings A/S and Bpifrance, with Invus and UI Investissement participation alongside existing investors Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, and Turenne Capital.

Deep Vector: $1.5 Million (Seed) Raised For Transforming Insurance Data Extraction

By Amit Chowdhry ● Jan 16, 2025

Deep Vector, an AI-based platform for analyzing underwriting documents, announced it closed a seed round of $1.5 million, co-led by Aperture Venture Capital and InsurTech NY. And Deep Vector helps insurers and brokers translate the influx of analog documents used for underwriting risk: claims loss runs, Acord forms, motor vehicle records, and business records into usable and actionable data.

PrettyDamnQuick: $25 Million (Series A) Closed For Operational Data Platform

By Amit Chowdhry ● Jan 16, 2025

PrettyDamnQuick (PDQ), an operational data platform for profitable commerce, announced that it closed a $25 million Series A funding round led by Peakspan Capital, with participation from existing investors TLV Partners and Moneta. And PDQ will utilize the funds to expand its market presence and accelerate the development of its cutting-edge checkout and shipping personalization engine, which helps mid-sized Direct-to-Consumer (D2C) e-commerce brands to boost revenue and compete more effectively with massive global entities like Amazon. So far, PDQ has raised $38 million.

Abstract: $4.8 Million (Seed) Raised For Regulatory Risk Management Platform

By Amit Chowdhry ● Jan 16, 2025

Abstract, an artificial intelligence company developing the first regulatory superintelligence platform, announced it raised $4.8 million in seed funding co-led by Bonfire Ventures and Communitas Capital. This latest funding round brings Abstract’s total funding to over $9 million.

Qventus: $105 Million (Series D) For AI-Based Health System Automation

By Amit Chowdhry ● Jan 16, 2025

Qventus, a provider of AI-based care automation software for health systems, announced a $105 million investment led by KKR, with additional participation from renowned investment firm Bessemer Venture Partners, and new strategic investors, including leading health systems Northwestern Medicine, HonorHealth, and Allina Health. And this funding follows a year of significant growth for Qventus, increasing its cadre of health system partners and expanding its team globally.

Labviva: $25 Million (Series B) Raised For Accelerating Life Sciences Product Development

By Amit Chowdhry ● Jan 16, 2025

Labviva, a leading AI procurement platform for life sciences, announced the closing of its $25 million Series B, bringing the total funding to $55 million. The round was led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures. And the funding reflects the company’s boom growth and escalating demand in Biopharma for automated supply chain and procurement solutions. In connection with the funding round, 53 Station’s co-founder and Managing Partner, Jason Pritzker, will join Labviva’s Board of Directors.

Clear Labs: $30 Million (Series D) Secured For Advancing Development Of Sequencing Solutions

By Amit Chowdhry ● Jan 16, 2025

Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has raised $30 million in its Series D financing. This funding round was led by a strategic investor, along with participation from existing investors, including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, and funds and accounts advised by T. Rowe Price Associates.

Red Sky Health: $3 Million (Seed) Closed For Optimizing Healthcare Claims Management

By Amit Chowdhry ● Jan 16, 2025

Red Sky Health (RSH), an AI-based platform designed to optimize healthcare claims management, announced it has raised $3 million in seed funding. The funding round was led by serial entrepreneur and investor Trevor Burgess, along with notable alumni from Charles River Data, Gleb Drobkov, and Mike Dezube, now key figures in Neptune Flood's data science leadership.

Colossal: $200 Million (Series C) Raised At $10.2 Billion Valuation For De-Extinction Technology

By Amit Chowdhry ● Jan 16, 2025

De-extinction company Colossal Biosciences announced $200 million in a Series C funding round by TWG Global, jointly led by Mark Walter and Thomas Tull. And Colossal’s additional strategic investors include funds such as USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak 6, and Draper Associates, and others and private investors including Robert Nelsen, Peter Jackson, Fran Walsh, Ric Edelman, Brandon Fugal, Paul Tudor Jones, Richard Garriott, Giammaria Giuliani, Sven-Olof Lindblad, Victor Vescovo, and Jeff Wilke.

Ubiety Technologies: $10 Million (Series A-1) Secured At $90 Million Valuation For Home Insights Platform

By Amit Chowdhry ● Jan 16, 2025

Ubiety Technologies announced that it has completed a $10 million Series A-1 financing. This funding will be used to enhance its product, accelerate the development of its proprietary AI engine, and expand go-to-market capabilities to meet the needs of its rapidly growing customer base.

Esphera SynBio: $2 Million (Seed) Funding Raised For Developing Nanomedicine Vaccines

By Amit Chowdhry ● Jan 16, 2025

Synthetic biology company Esphera SynBio announced the closing of a $2 million seed financing round. The funding builds on the company's advanced R&D activities and proceeds are directed at identifying an initial cancer vaccine clinical candidate and general corporate purposes. And seed investors GKCC and FACIT supported the financing.